Globalization, International Law, and Emerging Infectious Diseases

Globalization, international law, and emerging infectious diseases.

The global nature of the threat posed by new and reemerging infectious diseases will require international cooperation in identifying, controlling, and preventing these diseases. Because of this need for international cooperation, international law will certainly play a role in the global strategy for the control of emerging diseases. Recognizing this fact, the World Health Organization has alr...

International cooperation. Emerging infectious diseases.

Experts from the World Health Organization (WHO), the European Union (EU), the U.S. Department of Defense (DoD), and other organizations summarized existing and planned collaborations on emerging infectious diseases. The session was chaired by David Heymann, WHO, and James LeDuc, CDC. One speaker, V. Ramalingaswami, All India Institute of Medical Sciences, India, summarized lessons learned from...

Emerging infectious diseases and the law.

In ITI countries the antibiotic used is Zithromax (azithromycin), donated by Pfizer. A single oral dose of Zithromax once a year is as effective as the standard treatment of tetracycline eye ointment 2 times a day for 6 weeks. The ITI is currently working in five countries: Morocco, Tanzania, Mali, Ghana, and Vietnam. The ITI works with ministries of health to devise an operating plan and joins...

Mission impossible? International law and infectious diseases.

International Conference on Emerging Infectious Diseases

cials from the United States and 64 other countries gathered in Atlanta, Georgia, February 29 – March 3, 2004, for the fourth biennial International Conference on Emerging Infectious Diseases. The aims of the conference were to present the latest scientific information from a variety of disciplines on the new and emerging microbial threats to public health around the world and to encourage and ...